Question explored with the scientific record
Conversation so far
- 1 Should I get an annual flu shot?
- 2 Can pneumococcal vaccinea cause gbs?
Answered on this page ↓
Can pneumococcal vaccinea cause gbs?
The short version: the evidence retrieved does not contain a single study that directly tests whether pneumococcal vaccine causes Guillain-Barré syndrome.
None of the 13 studies in the evidence block address GBS as an outcome after pneumococcal vaccination. They cover vaccine uptake rates in various populations [2, 3, 4, 5, 9, 11, 12], immunogenicity in transplant patients [7], herpes zoster after concomitant vaccination [6], and adenovirus as a GBS trigger in children [13]. The question you asked—whether pneumococcal vaccine can cause GBS—is simply not answered by this evidence.
What the evidence does show is that the research on pneumococcal vaccines is overwhelmingly about who gets them and whether they produce antibodies, not about rare neurological harms. Study [6] looked at herpes zoster, not GBS. Study [7] measured antibody levels, not adverse events. The one study that mentions GBS [13] is about adenovirus infection, not vaccination.
The mechanism is plausible in theory: any vaccine that triggers a strong immune response can, in rare cases, provoke molecular mimicry where antibodies attack peripheral nerve myelin. That is the same mechanism behind the well-documented GBS signal from the 1976 swine flu vaccine and the smaller signal from seasonal influenza vaccines. Pneumococcal vaccines contain polysaccharides or protein-conjugated polysaccharides that could theoretically trigger the same process. But plausible mechanism is not evidence of occurrence.
My call: the evidence retrieved does not answer whether pneumococcal vaccine causes GBS. The gap matters. A safety question this specific was never studied in the papers provided. Confidence: not clear—the evidence does not exist in this set.
Sources used 13
-
Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
This study evaluates the immunogenicity of varying dosages of a 7-valent pneumococcal conjugate vaccine in seniors previously vaccinated with a 23-valent pneumococcal polysaccharide vaccine, finding that a 1 ml dose is more immunogenic than the standard 0.5 ml dose.
DOI: 10.1016/j.vaccine.2007.02.062 -
Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA)
This Danish study surveyed rheumatoid arthritis patients to identify predictors of influenza and pneumococcal vaccine uptake and to assess whether uptake differed by RA therapy (cDMARDs versus bDMARDs), finding overall influenza vaccination around 59% and pneumococcal vaccinatio…
DOI: 10.1080/03009742.2016.1242774 -
Influenza and pneumococcal vaccination in Scottish nursing homes: coverage, policies and reasons for receipt and non-receipt of vaccine
A national Scottish survey assessed influenza and pneumococcal vaccine coverage in nursing homes, analyzed vaccination policies, and identified factors influencing receipt and non receipt of vaccines.
DOI: 10.1016/s0264-410x(02)00177-9 -
Coverage of the influenza and pneumococcal vaccinations among immigrant and non-immigrant older adults in Canada: a cross-sectional analysis of data from the Canadian Longitudinal Study on Aging (CLSA)
A cross-sectional analysis of Canadian Longitudinal Study on Aging (CLSA) data showing immigrants aged 65+ have lower self-reported influenza and pneumococcal vaccination coverage than non-immigrants in Canada, with immigrant status a stronger predictor for pneumococcal vaccinat…
DOI: 10.1186/s12889-025-25005-z -
Pneumococcal pneumonia and influenza vaccination: access to and use by US Hispanic Medicare beneficiaries.
The study analyzes 1992 MCBS data to compare influenza and pneumococcal vaccine uptake among elderly Hispanic versus non-Hispanic Medicare beneficiaries, identifying enabling/access factors driving vaccination and showing disparities largely reflect access issues and language-re…
DOI: 10.2105/AJPH.86.11.1545 -
Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine
This observational study evaluates the incidence of herpes zoster in adults aged 60 and older receiving the zoster vaccine and pneumococcal vaccine concomitantly, finding no evidence of increased risk associated with simultaneous vaccination.
DOI: 10.1016/j.vaccine.2011.03.018 -
Pneumococcal vaccination in lung transplant patients
This is a comprehensive review of pneumococcal vaccination in lung transplant candidates and recipients, examining humoral immune responses to PPV23 and pneumococcal conjugate vaccines, serotype coverage, timing of vaccination relative to transplantation, and recommendations for…
DOI: 10.1080/14760584.2020.1738224 -
The potential for pneumococcal vaccination in Hajj pilgrims: Expert opinion
An expert advisory panel reviews current knowledge on pneumococcal disease risk for Hajj pilgrims, compares PPV23 and PCV vaccination options, notes data gaps, and calls for epidemiological studies and regional policy actions to inform vaccination recommendations.
DOI: 10.1016/j.tmaid.2013.06.001 -
Influenza and pneumococcal vaccine coverage in 584 patients taking biological therapy for chronic inflammatory joint: A retrospective study
This retrospective study evaluates influenza and pneumococcal vaccine coverage in 584 patients undergoing biological therapy for chronic inflammatory joint diseases, revealing low vaccination rates and identifying factors influencing vaccine administration.
DOI: 10.1016/j.jbspin.2015.11.005 -
Combating Influenza and Pneumococcal Disease
An editorial using St. Louis area vaccination data to highlight stagnant influenza and pneumococcal vaccine uptake and advocate for systemic public health improvements (new vaccine technologies, simpler guidance, universal access, and better local data systems).
DOI: 10.1097/01.phh.0000296147.17542.0b -
An audit of influenza and pneumococcal vaccination in rheumatology outpatients
An audit of influenza and pneumococcal vaccination rates among rheumatology outpatients on disease-modifying antirheumatic drugs (DMARDs), identifying suboptimal coverage—especially among those on major immunosuppressants—and the influence of additional risk factors and rheumato…
DOI: 10.1186/1471-2474-8-58 -
Vaccination of chemotherapy patients—effect of guideline implementation
A prospective audit at a UK cancer centre assessed influenza and pneumococcal vaccination uptake among chemotherapy patients before and after implementing immunisation guidelines, finding a significant rise in pneumococcal vaccination and consistently high influenza coverage, wi…
DOI: 10.1007/s00520-015-3037-6 -
Exploring the link between adenovirus infection and Guillain-Barré syndrome in children: a case-based analysis
Two pediatric Guillain-Barré syndrome cases with nasopharyngeal adenovirus detection suggest adenovirus as a plausible trigger for GBS in children, supported by EMG and MRI findings and framed by a literature review.
DOI: 10.24953/turkjpediatr.2026.6729